MCGLINN CAPITAL MANAGEMENT INC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 64 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.

Quarter-by-quarter ownership
MCGLINN CAPITAL MANAGEMENT INC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2013$228,000
-25.5%
30,300
-27.3%
0.52%
-30.7%
Q3 2013$306,000
-13.1%
41,700
-23.8%
0.75%
-22.4%
Q2 2013$352,00054,7000.96%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders